A060590 logo

CTCBIO Inc. Stock Price

KOSDAQ:A060590 Community·₩105.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A060590 Share Price Performance

₩4,430.00
-2240.00 (-33.58%)
₩4,430.00
-2240.00 (-33.58%)
Price ₩4,430.00

A060590 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

1 Risk
2 Rewards

CTCBIO Inc. Key Details

₩132.8b

Revenue

₩78.9b

Cost of Revenue

₩53.9b

Gross Profit

₩51.2b

Other Expenses

₩2.6b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
110.83
40.60%
2.00%
47.7%
View Full Analysis

About A060590

Founded
1993
Employees
245
CEO
Sun Cho Chang
WebsiteView website
www.ctcbio.com

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.

Recent A060590 News & Updates

These 4 Measures Indicate That CTCBIO (KOSDAQ:060590) Is Using Debt Reasonably Well

Dec 02
These 4 Measures Indicate That CTCBIO (KOSDAQ:060590) Is Using Debt Reasonably Well

Recent updates

No updates